乳腺癌中的新兴分子治疗标:病理识别和临床影响
Aysegul A Sahin1, Hui Chen1, Huang Xiao1
1Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Human pathology
|August 4, 2025
概括
准确的乳腺癌诊断和治疗依赖于分子标记物. 新兴的生物标志物和液体活检等技术为个性化护理和改善患者治疗结果提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物标志物发现发现
背景情况:
- 乳腺癌是一种复杂的疾病,需要超越传统生物标志物 (ER,PR,HER2) 的先进分子标志物.
- 基因组学的进步已经确定了内在的亚型,使个性化治疗和改善风险分层成为可能.
- 了解瘤微环境对于预测治疗反应至关重要.
研究的目的:
- 审查当前和新兴的乳腺癌生物标志物.
- 突出其在推进精密瘤学的作用.
- 讨论临床整合的挑战和未来方向.
主要方法:
- 关于乳腺癌生物标志物的当前文献的综述.
- 分析既有和新型分子技术 (基因组学,下一代测序,液体活检).
- 讨论高通量技术 (空间转录组学,多重免疫光).
主要成果:
- 已确定的生物标志物 (ER,PR,HER2) 是必不可少的,但对于疾病的完整复杂性是不够的.
- 基因组亚型,环林E,BRCA1/2突变和MMR缺乏提供预后/预测价值.
- 液体活检和先进的成像技术显示出对非侵入性监测和生物标志物发现的前景.
结论:
- 新型生物标志物和技术对于个性化乳腺癌治疗至关重要.
- 解决标准化和验证方面的挑战是临床翻译的关键.
- 持续的研究对于整合新的生物标志物和改善患者治疗结果至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:38Mitogens and the Cell Cycle
6.8K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.8K